Prosecution Insights
Last updated: May 29, 2026

Examiner: AHMED, TASNIM M

Tech Center 3700 • Art Units: 3763 3783

This examiner grants 80% of resolved cases

Performance Statistics

80.5%
Allow Rate
+10.5% vs TC avg
460
Total Applications
+5.9%
Interview Lift
1017
Avg Prosecution Days
Based on 437 resolved cases, 2023–2026

Rejection Statute Breakdown

0.5%
§101 Eligibility
12.2%
§102 Novelty
65.6%
§103 Obviousness
10.6%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17920157 MECHANISM UNIT FOR A DRUG DELIVERY DEVICE AND DRUG DELIVERY DEVICE Non-Final OA Sanofi
18022910 DRUG SYRINGES WITH A MECHANICAL STOP FOR A SECOND DOSE Non-Final OA JANSSEN PHARMACEUTICA NV
18737954 INJECTOR NEEDLE CAP AND/OR LINER REMOVER Non-Final OA West Pharma. Services IL, Ltd.
18547903 MICRONEEDLE ARRAY WITH AN INTERLOCKING FEATURE Non-Final OA WASHINGTON STATE UNIVERSITY
17464402 MEDICAL DEVICES FOR DELIVERY OF siRNA Non-Final OA VIVASOR, INC.
18338742 Injection Device Having Variable Dosing Non-Final OA Antares Pharma, Inc.
18265644 SQEEZABLE SUBCUTANEOUS PORT Non-Final OA Portal Access, Inc.
18034690 METHOD AND SYSTEM FOR DETERMINING AN OPTIMAL INSERTION SEGMENT IN A BLOOD VESSEL OF A PATIENT Non-Final OA BHEALTHCARE
17638295 INTESTINAL DIAGNOSTIC SCREENING DEVICE AND METHOD FOR TARGETED GASTROINTESTINAL THERAPY Non-Final OA AJM MED-I-CAPS LTD

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month